Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a millionaire-maker stock. The only problem is that it’s also a millionaire-destroyer stock. It all depends on timing. In 2016, shares traded at $0.20. At the start of 2019, they touched $30. In just three years, a $5,000 investment became $750,000. Then the cannabis bear market of 2019 occurred. The industry lost billions of dollars…
Read More
Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) was once the hottest pot company in the world. From late 2014 to early 2019, Cronos stock rose in value by nearly 4,000%. The marijuana bear market of 2019 changed everything. Last year, virtually every pot stock lost more than 50% of its value. Cronos went from a $12 billion company to a valuation of less than…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) finally reported its delayed fourth0quarter and full-year 2019 results on March 30. Much to investors’ disappointment, the company’s quarterly revenue growth in Canada was negative and massive inventory charges drowned spirits. There’s one more piece of information that could warrant a downward revision to the marijuana firm’s potential revenue growth rate. For a start, this was the…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…
Read More
Cannabis producer and innovation giant Cronos Group (TSX:CRON)(NASDAQ:CRON) announced on Monday that it will delay the release of its fourth quarter and full year 2019 earnings results originally slated for Thursday, February 27 as it has experienced a delay. No reason was given for the earnings release postponement, no new specific date was given for the delayed filings and the…
Read More
Cannabis investors have lost a significant portion of their investment since the last quarter of 2018. Investors were rightly concerned over the high valuation metrics of pot stocks, and this started the bear run for marijuana companies. Further, the revenue estimates for most cannabis companies seemed to have been overstated, as most analysts failed to consider the impact of Canada’s…
Read More
Few cannabis stocks are better positioned than Cronos Group (TSX:CRON)(NASDAQ:CRON). That’s because it has the backing of one of the most powerful, well-financed, most influential companies on the planet: Altria Group (NYSE:MO). Today, Altria is responsible for more than half of all U.S. cigarette sales. Its market cap exceeds $100 billion. That’s larger than every Canadian pot stock combined. With a $3…
Read More
Shares of leading cannabis company Cronos Group (TSX:CRON)(NASDAQ:CRON) fell over 25% in the last week. Why did Cronos Group investors lose a quarter of their market value in the week ended on November 15, 2019? Cronos Group announced its third-quarter results on November 12 and reported sales of $12.7 million — 238% higher compared to sales of $3.76 million in…
Read More
Cannabis firm Cronos Group (TSX:CRON)(NASDAQ:CRON) reported its third-quarter financial results on Wednesday this week and management has announced some significant changes to the business. Investors need be aware of the following fundamental changes to the company’s future operations and financial results presentations going forward. Here’s what you need to know. Big change in applicable accounting standards First, the company will…
Read More